Nereid Therapeutics
Cambridge
About Nereid Therapeutics
Nereid Therapeutics is discovering new disease treatments using proprietary technologies for generating, visualizing, and measuring liquid-liquid phase separation and the resulting biomolecular condensates.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: Less than $1M
- Total funding: $50.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Nov 2020)
- Website: nereidtx.com
- Phone: (617) 294-6790
Industries & Categories
Biotechnology, Health Care, Life Science
Canonical: https://fsome.com/organization/nereid-therapeutics-33774 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.